Exhibitor Spotlight Theater

Next-Generation Solutions in Drug Development: How NeoGenomics can streamline translational medicine from discovery to the clinic

Advances in technology in the past few years have created unprecedented opportunities to efficiently identify and characterize biomarkers of disease processes. Importantly, the use of spatial omics and comprehensive NGS discovery techniques can now address the complexity of the cellular network and tumor microenvironment using various high-dimensional exploration of both tissue and blood samples, at the genomic, transcriptomic, and proteomic, level to ascertain overall treatment responses. Our presentations will showcase the utility of innovative next-generation solutions focused on cancer biology while also addressing markers that may help in predicting clinical responses and mechanisms of resistance to therapy.

Presented by

• Kirsteen Maclean I Principal Scientist, Associate Director I NeoGenomics Laboratories
• Courtney Todorov I Senior Scientist, Scientific Manager I NeoGenomics Laboratories

This Exhibitor Spotlight Theater is a promotional activity and is not approved for continuing education credit. The content of this Exhibitor Spotlight Theater and opinions expressed by presenters are those of the sponsor or presenter and are not of the American Association for Cancer Research; (AACR®).